Disclosure of investigators' recruitment performance in multicenter clinical trials: A further step for research transparency

PLoS Medicine

Volumn 8, Issue 12, 2011, Pages

  Dal Ré, Rafael ^a   Moher, David ^b   Gluud, Christian ^c   Treweek, Shaun ^d   Demotes Mainard, Jacques ^e,f   Carné, Xavier ^g  

^a Clinical Research Program   (Spain)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e INSERM   (France)

^f European Clinical Research Infrastructures Network (ECRIN)   (France)

^g UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); FUNDING; HEALTH CENTER; MEDICAL LITERATURE; MULTICENTER STUDY (TOPIC); PEER REVIEW; PLANNING; PRACTICE GUIDELINE; REGISTRATION; RESEARCH SUBJECT; SAMPLE SIZE; CONFLICT OF INTEREST; ETHICS; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; PATIENT SELECTION; PERSONNEL;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; DISCLOSURE; HUMANS; MULTICENTER STUDIES AS TOPIC; PATIENT SELECTION; RESEARCH PERSONNEL;

EID: 84855174104     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001149     Document Type: Article

References (33)

1. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, et al. (2004) Clinical trial registration: a statement from the international Committee of Medical Journal Editors. Ann Intern Med 141: 477-478.
2. Sim I, Chan AW, Gulmezoglu AM, Evans T, Pang T, (2006) Clinical trial registration: transparency is the watchword. Lancet 367: 1631-1633.
3. World Medical Association (2008) Declaration of Helsinki. Available: http://www.wma.net/en/10home/index.html. Accessed 17 July 2011.
4. Food and Drug Administration Amendments Act of 2007. Available: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110_cong_public_laws&docid=f:publ085.110. Accessed 17 July 2011.
5. World Health Organization (2011) International Clinical Trials Registry Platform (ICTRP). Available: http://www.who.int/ictrp/en/. Accessed 13 October 2011.
6. National Institutes of Health (2011) ClinicalTrials.gov. Available: http://clinicaltrials.gov/. Accessed 22 May 2011.
7. McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, et al. (2006) What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials 7: 9.
8. Vale C, Stewart L, Tierney J, the UK Coordinating Committee for Cancer Research. National Register of Cancer (2005) Trends in UK cancer trials: results from the UK Coordinating Committee for Cancer Research National Register of Cancer Trials. Br J Cancer 92: 811-814.
9. Cheng SK, Dietrich MS, Dilts M, (2010) A sense of urgency: evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies. Clin Cancer Res 16: 5557-5563.
10. Dal-Ré R, Ortega R, Espada J, (1998) Eficiencia de los investigadores en la selección de los enfermos para ensayos clínicos: a propósito de un estudio multinacional.[Efficiency of investigators in recruitment of patients for clinical trials: a propos of a multinational study] Med Clin (Barc) 110: 521-523.
11. Malakoff D, (2008) Clinical trials and tribulations. Spiraling costs threaten gridlock. Science 322: 210-213.
12. Pich J, Carné X, Arnaíz JA, Gómez B, Trilla A, et al. (2003) Role of a research ethics committee in follow-up and publication of results. Lancet 361: 1015-1016.
13. Wise P, Drury M, (1996) Pharmaceutical trials in general practice: the first 100 protocols. An audit by the clinical research ethics committee of the Royal College of General Practitioners. BMJ 313: 1245-1248.
14. Decullier E, Lheritier V, Chapuis F, (2005) Fate of biomedical research protocols and publication bias in France: retrospective cohort study. BMJ 331: 19 doi:10.1136/bmj.38488.385995.8F.
15. International Conference on Harmonisation of technical requirements for Registration of Pharmaceuticals for Human Use (2006) ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice E6 (R1) June 1996. Available: http://www.ich.org/home.html. Accessed 17 July 2011.
16. Caldwell PHY, Hamilton S, Tan A, Craig JC, (2010) Strategies for increasing recruitment to randomized controlled trials: systematic review. PLoS Med 7: e1000368 doi:10.1371/journal.pmed.1000368.
17. Treweek S, Mitchell E, Pitkethly M, Cook J, Kjeldstrøm M, et al. (2010) Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev pp. MR000013.
18. Moher D, Dulberg CS, Wells GA, (1994) Statistical power, sample size and their reporting in randomized controlled trials. JAMA 272: 122-124.
19. Chan AW, Hróbjartsson A, Jørgensen KJ, Gøtzsche PC, Altman DG, (2008) Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols. BMJ 337: a2299.
20. Gluud C, (2006) The culture of designing hepato-biliary reandomised trials. J Hepatol 44: 607-615.
21. Bourgeois FT, Murthy S, Mandl KD, (2010) Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 153: 158-166.
22. Zarin DA, Tse T, Williams R, Califf RM, Ide NC, (2011) The ClinicalTrials.gov results database-update and key issues. N Engl J Med 364: 852-860.
23. Blair JEA, Zannad F, Konstam MA, Cook T, Traver B, et al. (2008) Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure. JACC 52: 1640-1648.
24. Ali M, Atula S, Bath PM, Grotta J, Hacke W, et al. (2009) Stroke outcome in clinical trials patients deriving from different countries. Stroke 40: 35-40.
25. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, et al. (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361: 1045-1057.
26. Kalb PE, Koehler KG, (2002) Legal issues in scientific research. JAMA 287: 85-91.
27. Steen RG, (2011) Retractions in the scientific literature: is the incidence of research fraud increasing? J Med Ethics 37: 249-253.
28. European Medicines Agency (2010) Clinical trials submitted in marketing authorization applications to the EMA. Overview of patient recruitment and geographical location of investigator sites. EMA/INS/GCP/154352/2010. 5 November 2010. Available: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2009/12/WC500016819.pdf. Accessed 17 July 2011.
29. Boulton G, Rawlins M, Vallance P, Walport M, (2011) Science as public enterprise: the case for open data. Lancet 377: 1633-1635.
30. Chan AW, (2011) Access to clinical trial data. BMJ 342: 117.
31. Walport M, Brest P, (2011) Sharing research data to improve public health. Lancet 377: 537-539.
32. Hopewell S, Altman DG, Moher D, Schulz KF, (2008) Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of editors and journal 'instructions to authors'. Trials 9: 20.
33. Treweek S, Loudon K, (2011) Incomplete reporting of recruitment information in breast cancer trials published between 2003 and 2008. J Clin Epidemiol 64: 1216-1222.